|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR-TRC-11002108 |
|
最近更新日期: Date of Last Refreshed on: |
2015-05-03 19:15:40 |
|
注册时间: Date of Registration: |
2011-12-27 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
肾移植供者术前行肾脏CT血管造影时间差异对受者移植物功能的影响. |
|
Public title: |
The influence of donors‘CTA time to the allgraft function of renal transplantation recipents. |
|
注册题目简写: |
肾移植供者CTA时间对受者肾功的影响. |
|
English Acronym: |
The effect of donor CTA time to receipient'renal function. |
|
研究课题的正式科学名称: |
肾移植供者术前行肾脏CT血管造影时间差异对受者移植物功能的影响. |
|
Scientific title: |
The influence of donors‘CTA time to the allgraft function of renal transplantation recipents. |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
谢礼波 |
研究负责人: |
林涛 |
|
Applicant: |
Libo Xie |
Study leader: |
tao lin |
|
申请注册联系人电话: Applicant telephone: |
+86 15208216640 |
研究负责人电话:
Study leader's |
+86 18980602093 |
|
申请注册联系人传真 : Applicant Fax: |
+86 028 85422451 |
研究负责人传真: Study leader's fax: |
+86 028 85422451 |
|
申请注册联系人电子邮件: Applicant E-mail: |
peterxielibo@163.com |
研究负责人电子邮件: Study leader's E-mail: |
dr.taolin@gmail.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
http://www.cd120.com |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
http://www.cd120.com |
|
申请注册联系人通讯地址: |
中国四川省成都市武侯区国学巷37号 |
研究负责人通讯地址: |
中国四川省成都市武侯区国学巷37号 |
|
Applicant address: |
No. 37, Guoxue Alley, Chengdu, Sichuan, People’s Republic of China |
Study leader's address: |
No. 37, Guoxue Alley, Chengdu, Sichuan, People’s Republic of China |
|
申请注册联系人邮政编码: Applicant postcode: |
610041 |
研究负责人邮政编码: Study leader's postcode: |
610041 |
|
申请人所在单位: |
四川大学华西医院泌尿外科 |
||
|
Applicant's institution: |
Department of Urology, West China Hospital, Sichuan University |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
否 |
||
|
Approved by ethic committee: |
No |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
伦理委员会批件附件: Approved file of Ethical Committee: |
||
|
批准本研究的伦理委员会名称: |
|
||
|
Name of the ethic committee: |
|
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2013-08-26 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
四川大学华西医院泌尿外科 |
||||||||||||||||||||||
|
Primary sponsor: |
Department of Urology, West China Hospital, Sichuan University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国四川省成都市武侯区国学巷37号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 37, Guoxue Alley, Chengdu, Sichuan, People’s Republic of China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
患者行CTA及术后检查均为自费 |
||||||||||||||||||||||
|
Source(s) of funding: |
patients pay CTA and postoperation check by themseves |
||||||||||||||||||||||
|
研究疾病: |
因供者CTA时间造成的肾移植受者造影剂相关肾病 |
||||||||||||||||||||||
|
Target disease: |
Contrast agent-associated nephrotoxicity among renal transplantation recipents due to donors‘CTA time |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
III期临床试验 | ||||||||||||||||||||||
|
Study phase: |
3 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
了解肾移植供者选择不同时间行CTA是否对对受者移植肾功能产生影响。 |
||||||||||||||||||||||
|
Objectives of Study: |
To detect wether the time of donor's CTA has influence with the recipent renal allgraft function. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
碘普罗胺 |
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
Ultravist Solution |
||||||||||||||||||||||
|
纳入标准: |
2012年5月-2012年12月在华西医院行供肾切取术的供者,其术前行CTA时间要么大于3周(门诊行CTA),要么小于1周(住院后行CTA);以及行活体肾移植术的受者。 |
||||||||||||||||||||||
|
Inclusion criteria |
Donors have nephretectomy and recipents have kidney transplantation in West China Hospital between May 2012 and Dec 2012. |
||||||||||||||||||||||
|
排除标准: |
术前1-3周行CTA的供者;免疫高危受者、二次移植受者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Donors have CTA 1-3w before nephretectomy;high sensitive recipents,second translantation recipent. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2012-05-01 00:00:00至 To 2013-03-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2014-04-01 00:00:00 至 To 2013-02-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由林涛教授按供者入院时间先后,按照电脑随机数据分为门诊行CTA组和住院行CTA组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
donors will be randomly divide by professor Lin Tao into two groups:CTA in outpatient and CTA in war |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
单盲:盲统计资料者。 |
|
Blinding: |
single-blind:only concealed to statistor. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
|
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
四川大学华西医院泌尿外科 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Department of Urology, West China Hospital, Sichuan University |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
四川大学华西公卫学院统计学教研室 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Department of statistics, Public health institute, Sichuan University |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |